Published in Medical Letter on the CDC and FDA, May 18th, 2008
Techalt is in the process of securing financing for expanding SRO's distribution channels, which includes securing significant contracts and obtaining over the counter ("OTC") approval from the Food and Drug Administration....
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.